Open Access

SCF promotes the production of IL‑13 via the MEK‑ERK‑CREB signaling pathway in mast cells

  • Authors:
    • Yimeng Wang
    • Hua Ma
    • Xiangnan Tao
    • Yulan Luo
    • Helong Wang
    • Jing He
    • Qiang Fang
    • Shujun Guo
    • Chuanwang Song
  • View Affiliations

  • Published online on: August 8, 2019     https://doi.org/10.3892/etm.2019.7866
  • Pages: 2491-2496
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Mast cells serve a key role in the occurrence and development of allergy. As an important growth factor of mast cells, stem cell factor (SCF) has an effect on the apoptosis, chemotaxis, adhesion, degranulation and other biological characteristics of mast cells. However, there are few studies regarding the effect of SCF signal on the production of cytokines from mast cells, particularly Th2 type cytokines. In the present study, the expression and secretion of IL‑13 in P815 cells stimulated by SCF were detected by fluorescence quantitative PCR and ELISA, and western blotting and EMSA were used to detect ERK phosphorylation and activation of CREB in stimulated P815 cells. The results demonstrated that the production of IL‑13 was significantly increased in P815 cells stimulated by SCF (1‑100 ng/ml; P<0.01). There was an obvious phosphorylation of ERK and CREB activation in P815 cells stimulated by SCF (50 ng/ml). Compared with the SCF single stimulation group, the production of IL‑13 was significantly reduced in P815 cells stimulated with U0126 (ERK‑MEK/pathway inhibitor) or H‑89 (CREB inhibitor) combined with SCF stimulation group (P<0.01). However, JSI‑124 (JAK/STAT3 pathway inhibitor), Wortmannin (PI3K/Akt pathway inhibitor) and PDTC (NF‑κB inhibitor) had no effect on the role of SCF promoting the P815 cells producing IL‑13. Therefore, SCF signaling promotes mast cell P815 to produce IL‑13, and this effect is associated with the MEK‑ERK‑CREB signaling pathway.

Related Articles

Journal Cover

October 2019
Volume 18 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, Y., Ma, H., Tao, X., Luo, Y., Wang, H., He, J. ... Song, C. (2019). SCF promotes the production of IL‑13 via the MEK‑ERK‑CREB signaling pathway in mast cells. Experimental and Therapeutic Medicine, 18, 2491-2496. https://doi.org/10.3892/etm.2019.7866
MLA
Wang, Y., Ma, H., Tao, X., Luo, Y., Wang, H., He, J., Fang, Q., Guo, S., Song, C."SCF promotes the production of IL‑13 via the MEK‑ERK‑CREB signaling pathway in mast cells". Experimental and Therapeutic Medicine 18.4 (2019): 2491-2496.
Chicago
Wang, Y., Ma, H., Tao, X., Luo, Y., Wang, H., He, J., Fang, Q., Guo, S., Song, C."SCF promotes the production of IL‑13 via the MEK‑ERK‑CREB signaling pathway in mast cells". Experimental and Therapeutic Medicine 18, no. 4 (2019): 2491-2496. https://doi.org/10.3892/etm.2019.7866